Novavax Shares Rise After Licensing Deal With Pfizer

All NewsJanuary 20, 2026

Novavax shares are trading higher Tuesday after the company announced it entered into a license agreement with Pfizer for Matrix-M adjuvant.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Novavax Shares Rise After Licensing Deal With Pfizer

The UCW Newswire : Financial, Business and Tech News

Recent Headlines

Macy’s $100 8-piece reversible chinoiserie comforter set with matching sheets is 67% off

Disney’s next earnings come with an unusual $600 million boost

Australian consumer sentiment sinks to four-year low as rates and living costs bite

Amazon has a 5-tier kitchen pantry cabinet with door storage for $90

Starbucks and Panera launching mystery boxes for holiday cups